Search

Author/Creator Zelba, Henning

1. A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer. Issue 1 (15th November 2019)

Authors:
Rammensee, Hans-Georg; Wiesmüller, Karl-Heinz; Chandran, P. Anoop; Zelba, Henning; Rusch, Elisa; Gouttefangeas, Cécile; Kowalewski, Daniel J.; Di Marco, Moreno; Haen, Sebastian P.; Walz, Juliane S.; Gloria, Yamel Cardona; Bödder, Johanna; Schertel, Jill-Marie; Tunger, Antje; Müller, Luise; Kießle...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 7:Issue 1(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Early disappearance of tumor antigen-reactive T cells from peripheral blood correlates with superior clinical outcomes in melanoma under anti-PD-1 therapy. Issue 12 (21st December 2021)

Authors:
Bochem, Jonas; Zelba, Henning; Spreuer, Janine; Amaral, Teresa; Gaissler, Andrea; Pop, Oltin T; Thiel, Karolin; Yurttas, Can; Soffel, Daniel; Forchhammer, Stephan; Sinnberg, Tobias; Niessner, Heike; Meier, Friedegund; Terheyden, Patrick; Königsrainer, Alfred; Garbe, Claus; Flatz, Lukas; Pawelec, ...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 9:Issue 12(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search